166 related articles for article (PubMed ID: 6578513)
1. Characterization of human hybridomas secreting antibody to tetanus toxoid.
Larrick JW; Truitt KE; Raubitschek AA; Senyk G; Wang JC
Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6376-80. PubMed ID: 6578513
[TBL] [Abstract][Full Text] [Related]
2. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
3. Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule.
Ziegler-Heitbrock HW; Reiter C; Trenkmann J; Fütterer A; Riethmüller G
Hybridoma; 1986; 5(1):21-31. PubMed ID: 2420699
[TBL] [Abstract][Full Text] [Related]
4. Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.
Kozbor D; Lagarde AE; Roder JC
Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6651-5. PubMed ID: 6292911
[TBL] [Abstract][Full Text] [Related]
5. UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.
Glassy MC; Handley HH; Hagiwara H; Royston I
Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6327-31. PubMed ID: 6604917
[TBL] [Abstract][Full Text] [Related]
6. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
Posner MR; Elboim H; Santos D
Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
[TBL] [Abstract][Full Text] [Related]
7. A human hybrid hybridoma.
Tiebout RF; van Boxtel-Oosterhof F; Stricker EA; Zeijlemaker WP
J Immunol; 1987 Nov; 139(10):3402-5. PubMed ID: 3119707
[TBL] [Abstract][Full Text] [Related]
8. A human monoclonal antibody specific for tetanus toxoid.
Olsson L; Mazauric T; Vincent-Falquet JC; Armand J
Dev Biol Stand; 1984; 57():87-91. PubMed ID: 6526153
[TBL] [Abstract][Full Text] [Related]
9. Experiences in the production of human monoclonal antibodies to tetanus toxoid.
Boyd JE; Hastings I; Farzad Z; James K; McClelland DB
Dev Biol Stand; 1984; 57():93-8. PubMed ID: 6526155
[TBL] [Abstract][Full Text] [Related]
10. [The establishment of human anti-tetanus toxoid hybridomas with in vitro immunized human tonsil cells].
Jiang ZQ; Sun PF; Ji YY; Yeh M; Kuroda K; Kamei M; Hashizume S
Shi Yan Sheng Wu Xue Bao; 1992 Sep; 25(3):237-42. PubMed ID: 1476015
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mouse-human hybridoma as a useful fusion partner for the establishment of mouse-human-human hybridoma secreting anti-tetanus toxoid human monoclonal antibody of IgM or IgG class.
Hirata Y; Sugawara I
Microbiol Immunol; 1987; 31(3):231-45. PubMed ID: 3613992
[TBL] [Abstract][Full Text] [Related]
12. [Production of human antitetanus antibodies by hybridomas].
Garchon HJ; Blancher A; Champommier F; Blanchard de Vaucouleurs A; Bach JF; Hainaut J
Rev Fr Transfus Immunohematol; 1983 Apr; 26(2):147-51. PubMed ID: 6879040
[TBL] [Abstract][Full Text] [Related]
13. Development of specific IgG-producing human hybridomas by fusions of lymphocytes from actively immunized persons.
Jahn S; Settmacher U; Haensel K; Kiessig S; Grunow R; Von Baehr R
Hybridoma; 1989 Oct; 8(5):529-33. PubMed ID: 2680900
[TBL] [Abstract][Full Text] [Related]
14. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
[TBL] [Abstract][Full Text] [Related]
15. Protective human hybridoma antibody to tetanus toxin.
Gigliotti F; Insel RA
J Clin Invest; 1982 Dec; 70(6):1306-9. PubMed ID: 7174795
[TBL] [Abstract][Full Text] [Related]
16. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
[TBL] [Abstract][Full Text] [Related]
17. Establishment of stable mouse/human-human hybrid cell lines producing large amounts of anti-tetanus human monoclonal antibodies with high neutralizing activity.
Kamei M; Hashizume S; Sugimoto N; Ozutsumi K; Matsuda M
Eur J Epidemiol; 1990 Dec; 6(4):386-97. PubMed ID: 2091939
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.
Stevens RH; Saxon A
J Clin Invest; 1978 Dec; 62(6):1154-60. PubMed ID: 311781
[TBL] [Abstract][Full Text] [Related]
19. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
Chiorazzi N; Wasserman RL; Kunkel HG
J Exp Med; 1982 Sep; 156(3):930-5. PubMed ID: 6286839
[TBL] [Abstract][Full Text] [Related]
20. Production of human-human hybridomas secreting antibody to sheep erythrocytes after in vitro immunization.
Strike LE; Devens BH; Lundak RL
J Immunol; 1984 Apr; 132(4):1798-803. PubMed ID: 6699402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
